Photo by atikahakhtar from unsplash
Current treatment of bullous pemphigoid (BP) is based on the long‐term use of topical and/or systemic corticosteroids, which are associated with a high rate of adverse events and increased mortality. Click to show full abstract
Current treatment of bullous pemphigoid (BP) is based on the long‐term use of topical and/or systemic corticosteroids, which are associated with a high rate of adverse events and increased mortality.
Keywords:
open multicentre;
multicentre randomized;
randomized clinical;
bullous pemphigoid;
clinical study;
methylprednisolone
Journal Title: British Journal of Dermatology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Dermatology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!